The impact of the CRP F23033, aimed at enhancing and strengthening the use of electron beam (e-beam) accelerators for treating biohazards is multifaceted. First of all, it was clearly demonstrated that electron beam accelerators effectively kill bacteria, viruses, and other pathogens by damaging their DNA/RNA, preventing reproduction. This technology can be used to disinfect medical supplies, protective equipment, and even wastewater, providing a rapid method to control pathogens. By treating biohazardous materials (such as medical waste or contaminated animal products) with e-beams, the spread of infectious diseases, which is crucial in preventing pandemics, can be significantly reduced. Second, as e-beam sterilization is a clean process, it significantly reduces the need for harsh chemicals (e.g., ethylene oxide, formaldehyde) traditionally used in sterilization. This minimizes the release of toxic byproducts, which is beneficial for both the environment and human health. Accelerated biodegradation of organic waste, like animal or plant byproducts, can help manage waste efficiently. Treated bio-waste can even be reused safely, potentially as fertilizer or other byproducts, contributing to a circular economy model. In addition, electron beam technology proved to be useful for food sterilization as it reduces or eliminates pathogens without significant alteration to the food's properties or nutritional content. This enhances food safety, shelf life, and supports export quality standards. Finally, this project encouraged the development of scalable, cost-effective e-beam technology, supporting new applications and research, from industrial sterilization to experimental treatments for other contaminants (e.g., pharmaceutical residues).